2024-04-01 08893093 2025-03-31 08893093 2024-04-01 2025-03-31 08893093 2024-03-31 08893093 2023-04-01 2024-03-31 08893093 uk-core:WithinOneYear 2024-03-31 08893093 uk-core:WithinOneYear 2025-03-31 08893093 uk-core:AfterOneYear 2024-03-31 08893093 uk-core:AfterOneYear 2025-03-31 08893093 uk-core:ShareCapital 2025-03-31 08893093 uk-core:ShareCapital 2024-03-31 08893093 uk-core:RetainedEarningsAccumulatedLosses 2025-03-31 08893093 uk-core:RetainedEarningsAccumulatedLosses 2024-03-31 08893093 uk-bus:Director1 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure 08893093 uk-bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 08893093 uk-bus:FRS102 2024-04-01 2025-03-31 08893093 uk-bus:FilletedAccounts 2024-04-01 2025-03-31 08893093 uk-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31
Wise Medical Reporting Ltd
Registered Number:08893093
For the year ended 31 March 2025
England and Wales
Unaudited Financial Statements
2
For the year ended 31 March 2025
Wise Medical Reporting Ltd
Contents Page
1
Statement of Financial Position
2 to 4
Notes to the Financial Statements
3
Registered Number :
08893093
As at 31 March 2025
Wise Medical Reporting Ltd
Statement of Financial Position
£
£
2024
2025
Notes
Fixed assets
Property, plant and equipment
31
42
2
31
42
Current assets
Trade and other receivables
9
-
3
12,013
Cash and cash equivalents
5,371
5,371
12,022
Trade and other payables: amounts falling due
within one year
(1,000)
(1,200)
4
11,022
4,171
Net current assets
Total assets less current liabilities
4,202
11,064
Trade and other payables: amounts falling due after
more than one year
(1,836)
(1,853)
5
2,349
Net assets
9,228
Capital and reserves
Called up share capital
100
100
Retained earnings
2,249
9,128
2,349
9,228
Shareholders' funds
For the year ended 31 March 2025 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006
The directors acknowledge their responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
b) preparing financial statements which give a true and fair view of the state of affairs of the company
as at the end of each financial year and of its profit or loss for each financial year in accordance with
the requirements of Section 394 and 395 and which otherwise comply with the requirements of the
Companies Act 2006 relating to financial statements, so far as applicable to the company.
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been deliver
ed.
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
1 of 4
4
Registered Number :
08893093
For the year ended 31 March 2025
Wise Medical Reporting Ltd
Statement of Financial Position Continued
Dr Simon Taggert Director
These financial statements were approved and authorised for issue by the Board on 28 May 2025 and were signed by:
The notes form part of these financial statements
2 of 4
5
For the year ended 31 March 2025
Wise Medical Reporting Ltd
Notes to the Financial Statements
Statutory Information
Wise Medical Reporting Ltd is a private limited company, limited by shares, domiciled in England and
Wales, registration number 08893093.
Principal place of business:
Warwick Lodge
6 Warwick Road
Hale
Cheshire
WA15 9NS
Registered address:
433 Chester Road
Manchester
M16 9HA
The presentation currency is £ sterling.
1. Accounting policies
Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A of
Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and
Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared
under the historical costs convention as modified by the revaluation of certain assets.
2. Property, plant and equipment
Computer
equipment
£
Cost or
valuation
At 01 April 2024
636
At 31 March 2025
636
Provision for depreciation and impairmen
t
At 01 April 2024
594
Charge for year
11
At 31 March 2025
605
At 31 March 2025
Net book value
31
At 31 March 2024
42
3 of 4
6
For the year ended 31 March 2025
Wise Medical Reporting Ltd
Notes to the Financial Statements Continued
3. Trade and other receivables
2024
2025
£
£
Other debtors
-
9
4. Trade and other payables: amounts falling due within one year
2024
2025
£
£
Other creditors
1,200
1,000
5. Trade and other payables: amounts falling due after more than one year
2024
2025
£
£
Other creditors
1,853
1,836
6. Average number of persons employed
During the year the average number of employees was 0 (2024 : 1)
4 of 4